Is a
Clinical Study attributes
NCT Number
Health Conditions in Trial
Trial Recruitment Size
890
Trial Sponsor
Clinical Trial Start Date
2004
0Study Completion Date
2006
0Clinical Trial Study Type
Interventional0
Interventional Trial Purpose
Treatment0
Intervention Type
Drug0
Interventional Trial Phase
Phase 30
Official Name
A Multicenter Study on the Efficacy, Safety and Pharmacokinetics of IgPro10 in Patients With Primary Immunodeficiency (PID)0
Last Updated
June 6, 2012
0Allocation Type
NA0
Intervention Model
Single Group Assignment0
Masking Type
None (Open Label)0
Other attributes
Intervention Treatment
Immunoglobulins Intravenous (Human)0
Study summary
The purpose of this study is to demonstrate the effect of IgPro10 on the prevention of serious bacterial infections in patients with primary immunodeficiency. As secondary endpoints the rate of overall infections, the tolerability and safety of IgPro10 are studied. A part of the patients are participating in a pharmacokinetic substudy.
Timeline
No Timeline data yet.
Further Resources
No Further Resources data yet.
